FDANonrulemakingFDA-2011-D-0835
Who commented on this docket
Draft Guidance for IRBs, Clinical Investigators, and Sponsors: Considerations When Transferring Clinical Investigation Oversight to Another IRB; Availability
1 organizations filed 1 public comment on Draft Guidance for IRBs, Clinical Investigators, and Sponsors: Considerations When Transferring Clinical Investigation Oversight to Another IRB; Availability, at the Food and Drug Administration. The comment window closed 5097d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 5097d ago
Commenters (1)
- Advanced Medical Technology Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.